Your browser doesn't support javascript.
loading
Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years: A Randomized Clinical Trial.
Zadnik, Karla; Schulman, Erica; Flitcroft, Ian; Fogt, Jennifer S; Blumenfeld, Louis C; Fong, Tung M; Lang, Eric; Hemmati, Houman D; Chandler, Simon P.
Affiliation
  • Zadnik K; The Ohio State University College of Optometry, Columbus.
  • Schulman E; SUNY College of Optometry, New York.
  • Flitcroft I; Centre for Eye Research, Dublin, Ireland.
  • Fogt JS; The Ohio State University College of Optometry, Columbus.
  • Blumenfeld LC; Eye Physicians of Central Florida, Maitland.
  • Fong TM; Vyluma Inc, Bridgewater, New Jersey.
  • Lang E; Vyluma Inc, Bridgewater, New Jersey.
  • Hemmati HD; Vyluma Inc, Bridgewater, New Jersey.
  • Chandler SP; Vyluma Inc, Bridgewater, New Jersey.
JAMA Ophthalmol ; 141(10): 990-999, 2023 Oct 01.
Article in En | MEDLINE | ID: mdl-37261839

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Language: En Journal: JAMA Ophthalmol Year: 2023 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Language: En Journal: JAMA Ophthalmol Year: 2023 Document type: Article Country of publication: Estados Unidos